Effect of Aloe Vera Gel as an Intra Canal Medicament
1 other identifier
interventional
60
1 country
1
Brief Summary
This research will overview the effect of aloe vera gel (AVG) as intra canal medicament in patients with asymptomatic periapical lesions. It will provide endodontists with scientific evidence regarding the beneficial use of AVG as an intracanal medicament owing to its superior antibacterial and analgesic properties as compared to routinely used commercial intra canal medicaments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2023
CompletedFirst Submitted
Initial submission to the registry
January 29, 2024
CompletedFirst Posted
Study publicly available on registry
February 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2024
CompletedMay 21, 2025
May 1, 2025
9 months
January 29, 2024
May 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence or absence of signs and symptoms of the patient
Patients in both the groups will be recalled after one week. They will be assessed clinically for either presence or absence of signs and symptoms. 1. In cases of absence of clinical signs and symptoms, endodontic treatment will be completed. 2. In cases where patient returns with presence of clinical signs and symptoms, dressing will be removed, and canals will be irrigated with sodium hypochlorite followed by saline. After drying the canals, in group A, AVG will be placed in the canals and tooth restored temporarily while in group B, cotton pellet will be placed in the canals and tooth restored temporarily. The patients will be recalled after two weeks. 3. If a patient reports with acute symptomsin either of the groups, the protocols to manage acute infection will be followed.
One week and 3 weeks
Study Arms (2)
Intervention Group
EXPERIMENTALFresh AVG will be prepared. It will be placed as intracanal medicament after cleaning and shaping in patients with asymptomatic periapical lesions
Control Group
NO INTERVENTIONNo intracanal medicament will be placed
Interventions
A fresh aloe vera (Aloe Barbadensis) leaf will be plucked from the plant. The leaf will be washed with normal saline, peeled with scalpel and the inner gel will be blended in a blender to convert it into a watery consistency. The solution will be stored in an autoclaved flask.
Eligibility Criteria
You may qualify if:
- Both male and female patients presenting with asymptomatic periapical lesions in permanent teeth
You may not qualify if:
- History of allergy to AVG
- Comorbidities likely to impair healing
- Pregnant women
- History of previous endodontic treatment in the same tooth
- Presence of pulp calcification
- Internal or external root resorption
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Islamabad Dental Hospital
Islamabad, Federal, 44000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saima Azam, BDS,FCPS
Islamabad Dental Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2024
First Posted
February 6, 2024
Study Start
November 30, 2023
Primary Completion
August 20, 2024
Study Completion
November 15, 2024
Last Updated
May 21, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share